US5508260A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions
Assignee: Amylin Pharmaceuticals LLC
•
Filing: 1994-06-10
•
Granted: 1996-04-16
•
Expires: 2014-06-10
Abstract
Abstract Methods for treatment of diabetes and other insulin-requiring conditions by administering insulin and a calcitonin with or without amylin, and methods for treatment of hypoglycemic conditions by administering a calcitonin alone or in combination with glucagon and/or an amylin, and related compositions.
Inventors
- 👤 Kevin Beaumont
- 👤 Andrew A. Young
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 10:14
CPC Classifications
A; A61; A61K; A61K38/00; A61K38/16; A61K38/17; A61K38/22; A61K38/28; A61K38/23; A61K38/26; A61K49/00; A61K49/0004; A61K49/0008; A61P; A61P3/00; A61P3/06
Claims Analysis
Total Claims: 9
Claim 1
Independent Claim
21 words
A composition comprising a therapeutically effective amount of a calcitonin and an insulin admixed in a form suitable for therapeutic administration.
Claim 2
Dependent Claim
21 words
A composition comprising a therapeutically effective amount of a calcitonin and an insulin admixed in a form suitable for therapeutic administration.
Claim 3
Dependent Claim
19 words
The composition of claim 1 wherein the effective amount of the calcitonin is about 0.01 mg to 1.0 mg.
Claim 4
Dependent Claim
22 words
The composition of claim 1 wherein said calcitonin is selected from the group consisting of calcitonins of avian origin and telost origin.
Claim 5
Dependent Claim
11 words
The composition of claim 1 wherein said calcitonin is chicken calcitonin.
Claim 6
Dependent Claim
20 words
The composition of claim 1 wherein the calcitonin is selected from the group consisting of eel calcitonin and salmon calcitonin.
Claim 7
Dependent Claim
31 words
The composition of claim 1 wherein the ratio of the therapeutically effective amount of the calcitonin and the therapeutically effective amount of the insulin is from about 1:1 to about 1:20.
Claim 8
Dependent Claim
11 words
The composition of claim 1 wherein said ratio is about 1:10.
Claim 9
Dependent Claim
9 words
The composition of claim 1 further comprising an amylin.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1999-04-16 | 1999-10-16 | 2000-04-16 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2003-04-16 | 2003-10-16 | 2004-04-16 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2007-04-16 | 2007-10-16 | 2008-04-16 | $7700.00 | Window Closed / Lapsed |